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Summary
Owing to its wide metabolic versatility and physio-
logical robustness, together with amenability to
genetic manipulations and high resistance to stress-
ful conditions, Pseudomonas putida is increasingly
becoming the organism of choice for a range of
applications in both industrial and environmental
applications. However, a range of applied synthetic
biology and metabolic engineering approaches are
still limited by the lack of speciﬁc genetic tools to
effectively and efﬁciently regulate the expression of
target genes. Here, we present a single-plasmid
CRISPR-interference (CRISPRi) system expressing a
nuclease-deﬁcient cas9 gene under the control of
the inducible XylS/Pm expression system, along with
the option of adopting constitutively expressed
guide RNAs (either sgRNA or crRNA and tracrRNA).
We showed that the system enables tunable, tightly
controlled gene repression (up to 90%) of chromoso-
mally expressed genes encoding ﬂuorescent pro-
teins, either individually or simultaneously. In
addition, we demonstrate that this method allows for
suppressing the expression of the essential genes
pyrF and ftsZ, resulting in signiﬁcantly low growth
rates or morphological changes respectively. This
versatile system expands the capabilities of the cur-
rent CRISPRi toolbox for efﬁcient, targeted and con-
trollable manipulation of gene expression in P.
putida.
Introduction
Pseudomonas putida KT2440 is Gram-negative soil bac-
terium and the microbial cell factory of choice for many
applications in biotechnology due to a number of unique
qualities. It is endowed with considerable metabolic ver-
satility, a remarkable tolerance to various stress condi-
tions as well as rapid growth with simple nutrient
requirements (Nelson et al., 2002; Martins dos Santos
et al., 2004; Poblete-Castro et al., 2012, 2020; Nikel
et al., 2014, 2016; Belda et al., 2016). Moreover, this
bacterium is equipped with a unique glycolysis, the
EDEMP cycle, resulting in catabolic NAD(P)H overpro-
duction that can be used as reducing power for biocatal-
ysis or to counteract oxidative stress (Nikel et al., 2015).
All these traits render this bacterium a robust platform
for a range of industrial and environmental applications.
In connection to this, the available toolbox for manipulat-
ing its genome and metabolism is still under extensive
development to further enhance the applicability of P.
putida as a cell platform (Calero and Nikel, 2019;
Leprince et al., 2012; Martınez-Garcıa and de Lorenzo,
2019).
In an effort to broaden the existing toolbox, many
groups have focused on clustered regularly interspaced
short palindromic repeats (CRISPR)/CRISPR-associated
protein (Cas9)-based methods for knocking-out or knock-
ing-down target genes in P. putida. Recently, type II
CRISPR/Cas systems have been utilized in combination
with the k-Red system, SSR recombinases or the I-SceI
meganuclease for precise gene deletion (Martınez-
Garcıa and de Lorenzo, 2011; Mougiakos et al., 2017;
Sun et al., 2018; Aparicio et al., 2019, 2020; Wirth et al.,
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2020). Engineered catalytically inactive variants of the
Cas9 protein (dead Cas9, dCas9) have been shown to
act as a transcription repressor in Pseudomonas strains,
including P. putida KT2440. Tan et al. (2018), for
instance, used a two-plasmid CRISPR interference
(CRISPRi) system, based on the type II dCas9 homo-
logue of Streptococcus pasteurianus. In this example,
dCas9 from S. pasteurianus could be harnessed for efﬁ-
cient CRISPRi-mediated downregulation of genes,
requiring speciﬁc protospacer adjacent motif (PAM)
sequences (50-NNGTGA-30 or 50-NNGCGA-30, where N
represents any nucleotide). These PAM sequences,
however, are signiﬁcantly less abundant in the genome
of P. putida KT2440 in comparison with the simpler PAM
motif 5’-NGG-3’, associated with the most commonly
used Cas9 from Streptococcus pyogenes (SpCas9).
Recently, two alternative SpdCas9-based CRISPRi sys-
tems were developed and explored in Pseudomonas
species (Sun et al., 2018; Kim et al., 2020). Both sys-
tems were demonstrated to be functional for repression
of genes encoding ﬂuorescent proteins, and Kim et al.
(2020) also employed CRISPRi for metabolic engineer-
ing via gene repression by depleting the GlpR regulator
to enhance the glycerol-dependent synthesis of meval-
onate. Other examples on the development of CRISPRi
systems have been reported for P. aeruginosa (Peters
et al., 2019; Qu et al., 2019) and P. ﬂuorescens (Noirot-
Gros et al., 2019). While the CRISPRi toolbox for Pseu-
domonas species offers alternatives depending on the
intended application (ranging from fundamental studies
to simple metabolic engineering manipulations), the tech-
niques applied so far are afﬂicted by either leaky expres-
sion of the components or limited ability to titrate
repression levels – thus restricting the applicability of the
tool in complex engineering approaches. Moreover, the
possibility of performing multiple, simultaneous knock-
downs in gene expression with minimal cloning efforts is
still largely missing.
Here, we present an expanded CRISPRi toolbox allow-
ing for the tunable regulation of one or multiple target
genes in Pseudomonas species. Speciﬁcally, we have
developed a set of modular, composable vectors encod-
ing CRISPRi systems using either (i) non-coding trans-ac-
tivating CRISPR RNA (tracrRNA) and the CRISPR locus
needed for CRISPR RNA (crRNA) generation, present in
the native type II CRISPR/Cas9 system of S. pyogenes
(Cong and Zhang, 2015), or (ii) a single gRNA (sgRNA) in
short fusion form of tracrRNA and crRNA (Jinek et al.,
2012). The immense majority of the already developed
tools have utilized sgRNAs due to simplicity of working
with a single RNA molecule (Zalatan et al., 2015; Deaner
and Alper, 2017; Rousset et al., 2018). In general, the efﬁ-
ciency of using just sgRNA or both tracrRNA and crRNA
was observed to be comparable – although the
architecture of crRNA allows for a rapid and simple clon-
ing strategy when generating multiplex crRNA arrays.
Therefore, in this study we tested and employed both
sgRNA- and crRNA-based CRISPRi systems in P. putida
KT2440, and we describe alternative protocols for efﬁcient
downregulation of the expression of single or multiple tar-
get genes. Furthermore, we compared the efﬁciency of
three different inducible expression systems to control the
expression levels of the SpdCas9 gene, and showed that
the XylS/Pm expression system was able to accurately
modulate repression levels by adjusting the amount of
inducer (3-methylbenzoate, 3-mBz) – thus resulting in a
tunable, titrable CRISPRi system. Additionally, we demon-
strate that CRISPRi-mediated downregulation of gene
expression is more efﬁcient in a P. putida strain lacking
the main component of the homologous recombination
machinery, RecA. Our study expands the currently avail-
able CRISPRi toolbox, enabling to gain insights on tran-
scriptional repression in non-model bacteria, and allowing
for depletion of one or several proteins of interest to sup-
port rational metabolic engineering of P. putida.
Overview of the workﬂow
The overall gene downregulation procedure begins with
the construction of the target-speciﬁc vector pCRi
(Table 1 and extended explanation below), followed by
plasmid transformation in the strain of interest and induc-
tion of the system for targeted repression (Fig. 1). The
whole procedure typically takes around 6 days. All bac-
terial strains used in this study are listed in Table S1 in
the Supporting Information, and the speciﬁc steps of the
protocol are detailed below.
Overview and construction of derivatives of the pCRi
vector
To expand the CRISPRi toolbox, we constructed a set of
vectors that harbour SpdCas9, along with either the
native gRNAs (crRNA and tracrRNA) or its short fusion
form (sgRNA). The SpdCas9 gene and the correspond-
ing gRNAs were expressed from a single vector using
the backbone pSEVA441. This approach enabled to
construct composable plasmids, the modules of which
can be swapped at the user’s will (Silva-Rocha et al.,
2013; Martınez-Garcıa et al., ). Both gRNAs were placed
under constitutive expression of either the native Sp pro-
moter (crRNA) or the synthetic, constitutive PEM7 pro-
moter (Nikel et al., 2013; PEM7 ? sgRNA), while the
transcription of SpdCas9 was driven by inducible expres-
sion systems. The level of constitutive expression
brought about by the PEM7 promoter was shown to be
appropriate for expression of the sgRNAs tested in this
work, and other versions of the same promoter
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(displaying different strengths) can be implemented if
needed (Zobel et al., 2015). In this context, the inducible
expression of SpdCas9 would enable tunable repression
levels – allowing, in turn, for the interference of essential
genes expression as well as controlling the repression
timing. First, we created a set of sgRNA-based vectors
by using different modules for inducible expression of
SpdCas9: XylS/Pm, ChnR/PchnB or CprK1/PDB3 (Kemp
et al., 2013; Silva-Rocha et al., 2013; Benedetti et al.,
2016; Martınez-Garcıa et al., ), which resulted in vectors
pMCRi, pCCRi and pDCRi respectively (Fig. 2A). We
have selected these three inducible expression systems
as they are known to be active in P. putida, and they
are titrable (i.e. promoter output varies as a conse-
quence of increasing concentrations of the inducer) to
different extents (Martınez-Garcıa et al., ). The well-char-
acterized XylS/Pm expression system was observed to
be the most effective mediating the repression of target
genes, and we proceeded further in constructing the
crRNA-based vector pGCRi by adopting this system.
Vector pGCRi consists of three main functional ele-
ments: (i) a GC-rich, dead SpCas9 version [a codon-opti-
mized SpdCas9 for Streptomyces species, termed
GCSpdCas9 (Cobb et al., 2015)] under the control of the
XylS/Pm expression system, (ii) the tracrRNA under the
control of the native, constitutive Sp promoter and (iii)
the leader-crRNA. Streptococcus species have a rela-
tively low average genomic GC-content (~ 41.2%), while
Pseudomonas and Streptomyces display high average
genomic GC-content (~ 60%). We thus reasoned that
the GCSpdCas9 gene (displaying a GC-content ~ 62%)
could be suitable for CRISPRi in P. putida as compared
to the wild-type version of SpdCas9 (having a GC-con-
tent ~ 45%). Additionally, to enable one-step assembly
Table 1. Plasmids used in this work.
Name Relevant features Source or reference
pSEVA448 Cloning vector; oriV (pRO1600/ColE1); XylS, Pm; Sm
R/SpR Silva-Rocha et al. (2013)
pSEVA421-Cas9tr pSEVA421 derivative bearing the SpCas9 gene and a tracrRNA module; oriV
(RK2); SmR/SpR
Aparicio et al. (2018)
pSEVA231-CRISPR pSEVA231 derivative bearing the CRISPR array; oriV(pBBR1); KmR Aparicio et al. (2018)
pCRISPomyces-1 CRISPR array plasmid, oriT, rep[pSG5(Ts)], oriV(ColE1), GC-rich SpCas9
gene (GCSpdCas9), tracrRNA module; ApR
Cobb et al. (2015)
pSEVA441 Cloning vector; oriV(pRO1600/ColE1); SmR/SpR Silva-Rocha et al. (2013)
pMCRi Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? SpdCas9, PEM7 ? sgRNA; Sm
R/SpR
This work
pMCRi_gfp Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? SpdCas9, PEM7 ? msfgfp-speciﬁc sgRNA; SmR/SpR
This work
pMCRi_pyrF Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? SpdCas9, PEM7 ? pyrF-speciﬁc sgRNA; Sm
R/SpR
This work
pMCRi_ftsZ Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? SpdCas9, PEM7 ? ftsZ-speciﬁc sgRNA; Sm
R/SpR
This work
pMCRi_yfp Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? SpdCas9, PEM7 ? yfp-speciﬁc sgRNA; Sm
R/SpR
This work
pCCRi Plasmid for CRISPRi; oriV(pRO1600/ColE1), chnR, PchnB ? SpdCas9,
PEM7 ? sgRNA; Sm
R/SpR
This work
pCCRi_gfp Plasmid for CRISPRi; oriV(pRO1600/ColE1), chnR, PchnB ? SpdCas9,
PEM7 ? sgRNA; PEM7 ? msfgfp-speciﬁc sgRNA; SmR/SpR
This work
pDCRi Plasmid for CRISPRi; oriV(pRO1600/ColE1), cprK1, PDB3 ? SpdCas9,
PEM7 ? sgRNA; Sm
R/SpR
This work
pDCRi_gfp Plasmid for CRISPRi; oriV(pRO1600/ColE1), cprK1, PDB3 ? SpdCas9,
PEM7 ? sgRNA; PEM7 ? msfgfp-speciﬁc sgRNA; SmR/SpR
This work
pGCRi-R Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? GCSpdCas9, crRNA cassette with eforRed; Sm
R/SpR
This work
pGCRi_yfp Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? GCSpdCas9, yfp-speciﬁc crRNA; Sm
R/SpR
This work
pGCRi_ftsZ Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? GCSpdCas9, ftsZ-speciﬁc crRNA; Sm
R/SpR
This work
pGCRi_pyrF Plasmid for CRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? GCSpdCas9, ftsZ-speciﬁc crRNA; Sm
R/SpR
This work
pCRiMs Plasmid for mCRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? SpdCas9, PEM7 ? ftsZ-speciﬁc sgRNA, PEM7 ? yfp-speciﬁc sgRNA,
PEM7 ? mCherry-speciﬁc sgRNA; Sm
R/SpR
This work
pCRiMc Plasmid for mCRISPRi; oriV(pRO1600/ColE1), xylS (cured of BsaI-sites),
Pm ? GCSpdCas9, tracrRNA module, ftsZ-speciﬁc crRNA, yfp-speciﬁc
crRNA, mCherry-speciﬁc crRNA; SmR/SpR
This work
Antibiotic markers and abbreviations: Ap, ampicillin; Km, kanamycin; Gm, gentamicin; Sm, streptomycin; and Sp, spectinomycin; Ts, tempera-
ture-sensitive replicon; mCRISPRi, multiplex CRISPR interference.
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of single or multiple spacers into vector pGCRi via
Golden Gate cloning and to simplify the selection pro-
cess, we engineered the crRNA cassette by incorporat-
ing an eforRed chromoprotein construct (BBa_K592012;
endowed with a constitutive promoter and a ribosome
binding site, RBS) ﬂanked by two BsaI recognition sites
between the two direct repeats (DRs) (Fig. 2B). When
accumulated in cells containing this construct, the
eforRed chromoprotein from the coral Echinopora for-
skaliana (Alieva et al., 2008) confers a pink or reddish
coloration to the colonies. In this way, when ligation of a
spacer is successful, the reporter is split and the E. coli
transformants containing the intended constructs appear
white instead of reddish. These operations do not affect
the overall efﬁciency of transformation while they greatly
facilitate the screening. The construction of the sgRNA-
based vectors was done essentially according to Wirth
et al. (2020). A detailed description of the pGCRi vector
construction, including the list of oligonucleotides used
for cloning functional modules into both vectors
(Table S2), is given in the Supporting Information.
Protocol for CRISPRi-mediated downregulation of
one or multiple targets
Spacer design and selecting a suitable target sequence
The CRISPRi system requires a speciﬁc spacer
sequence in the gRNA, which determines the binding
site of SpdCas9. This sequence has to be selected
speciﬁcally for each target as a 20-nt spacer for the
Fig. 1. Overview of the workﬂow for CRISPRi-mediated gene knock-down in Pseudomonas putida. Day 1: Choose a PAM sequence (50-NGG-
30, where N represents any nucleotide) within the non-template DNA strand sequence of the target gene. For efﬁcient gene repression, we rec-
ommend to choose a PAM within the promoter sequence, or, if the promoter is not clearly deﬁned or if it overlaps with a coding sequence,
chose the PAM closest to the start ATG codon. Design and order two oligonucleotides for cloning of the spacer (upstream the PAM, following
the format 50-spacer-NGG-30) in either sgRNA or crRNA. Day 2: Anneal single-strand DNA oligonucleotides by reverse cooling to form a dou-
ble-stranded DNA spacer-insert array and clone it into the respective derivative of vector pCRi. Transform a suitable cloning E. coli strain and
incubate the plates overnight (under streptomycin selection). Day 3: Inoculate three transformants in liquid cultures and grow the cultures over-
night. Day 4: Purify three independent plasmids and send them out for sequence veriﬁcation by DNA sequencing. Transform the target Pseu-
domonas strain with isolated and sequence-veriﬁed plasmids, and incubate the plates under streptomycin selection. Day 5: Inoculate a fresh
culture in the appropriate medium with veriﬁed Pseudomonas colonies and the additives needed, and incubate the cultures overnight. Day 6:
Perform CRISPRi-mediated gene downregulation in the presence of 1 mM 3-methylbenzoate (or other inducer concentrations as needed) to
activate the system
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sgRNA or a 30-nt spacer for the crRNA array (Jinek
et al., 2012; Cong et al., 2013). In both cases, it must be
immediately followed by a PAM (5’-NGG-3’). DNA strand
speciﬁcity is relevant for CRISPRi, and targeting the
non-template strand is crucial for efﬁcient repression –
whereas targeting the template DNA strand of the coding
sequence is less effective or not effective at all (Larson
et al., 2013). It has also been shown that the downregu-
lation effect is the most efﬁcient when dCas9 binds to
the promoter sequence (Qi et al., 2013; Tan et al.,
2018). Bacterial promoters can be predicted using freely
available in silico tools (such as online tool BPROM from
Softberry.com). In case that there is no available PAM in
the promoter sequence or if the promoter is poorly
deﬁned or overlaps with other coding sequences or pro-
moters, the spacer sequence should be chosen on the
non-template strand, closest to the beginning of the start
ATG codon of the target gene. To avoid off-target
effects, the spacer sequence should be unique. To
ensure that this is the case, a simple BLAST analysis
(Ladunga, 2017) against the complete genomic DNA
sequence of the target Pseudomonas strain (Winsor
et al., 2016) should reveal no sequence similarities.
Assembly of a target-speciﬁc CRISPRi vector in E. coli
The vectors described herein contain two BsaI (a type
IIS restriction enzyme targeting the sequence 50-
GGTCTC(N1)/(N5)-30, where N represents any nucleo-
tide) recognition sites that are placed upstream of the
sgRNA fusion construct. These recognition targets are
placed in either an inverted orientation (to insert a 20-nt
spacer) or a forward orientation between the DRs of the
crRNA cassette (to insert a 30-nt spacer). Further lin-
earization of the vector by treatment with BsaI allows for
the incorporation of a spacer-insert with unique over-
hangs, resulting in a target-speciﬁc vector that expresses
SpCas9. Below we present two cloning strategies for
addition of speciﬁc spacers into the corresponding
RNAs.
Fig. 2. Overview of key expression vectors constructed for CRISPRi-mediated knock-down of gene expression in Pseudomonas putida. A. The
sgRNA-based, XylS/Pm-inducible CRISPRi vector pMCRi. Vector pMCRi contains SpdCas9 under the control of the XylS/Pm expression system
and a constitutively expressed sgRNA cassette. The sgRNA cassette is composed by the synthetic, constitutive PEM7 promoter followed by the
sgRNA chimera, spanning three domains: a 20-nt region for target-speciﬁc binding, a 42-nt hairpin for dCas9 binding (dCas9 handle) and a 40-
nt transcription terminator (Sp Terminator) derived from S. pyogenes. To clone the target spacer, two BsaI recognition sites have been incorpo-
rated between the PEM7 promoter and the sgRNA cassette. B. The crRNA-based CRISPRi vector pGCRi-R. This vector contains a GC-rich
SpdCas9 gene (the expression of which is placed under control of the XylS/Pm expression system), a constitutively expressed crRNA cassette
and the constitutively expressed tracrRNA. The crRNA cassette is formed by an AT-rich sequence (leader) that contains a promoter driving the
transcription of the crRNA (Pul et al., 2010) and the two direct repeats (DRs) with an intervening gene encoding the eforRed chromoprotein
from Echinopora forskaliana (expressed from the constitutive BBa_J23100 Anderson promoter and equipped with the BBa_B0034 ribosome
binding site). The crRNA cassette is ﬂanked by two BsaI recognition sites to facilitate cloning the target spacer sequence. If the target spacer is
successfully assembled by Golden Gate cloning into vector pGCRi, the eforRed reporter gene is split (and inactivated), and the resulting E. coli
transformants will appear white instead of reddish when isolated on solid culture medium plates
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sgRNA design and construction of the pCRi_target
vector. Design and order two oligonucleotides that are
complementary to each other. The ﬁrst oligonucleotide
contains the 20-nt spacer sequence from non-template
strand of target gene and ﬂanked at the 50-end with 50-
GCGCG-30. The second oligonucleotide contains a
reverse complement 20-nt spacer sequence as
mentioned above, with the addition of a 50-AAAC-30 motif
to its 50-end and a C nucleotide to its 3’-end.
For example, if the pyrF gene (PP_1815, encoding
orotidine 50-phosphate decarboxylase, an essential activ-
ity for growth of P. putida in minimal media) is to be tar-
geted, the resulting sequences are as follows:
oligonucleotide 1 (EK.pyrF-F), 50-GCG CGG GAA ATC
CAG GGC GAC GAT C-30; and oligonucleotide 2
(EK.pyrF-R), 50-AAA CGA TCG TCG CCC TGG ATT
TCC C-3’ (Table S2 in the Supporting Information). In
these oligonucleotides, the nucleotides in bold represent
BsaI-compatible overhangs for efﬁcient ligation of the
spacer. To perform a ligation reaction with the linearized
pCRi vector, oligonucleotides have to be phosphorylated
at the 50-end, which could be done either by in situ phos-
phorylation using T4 polynucleotide kinase (PNK) or by
chemical modiﬁcation during oligonucleotide synthesis.
Step-by-step procedure (cloning of a construct to target
a single gene).
i. Digest vector pCRi with BsaI (or its Eco31I isoschizo-
mer; New England Biolabs Inc., Ipswich, MA, USA)
according to the manufacturer’s recommendations. In
order to purify the linearized plasmid after digestion,
perform electrophoresis of the digestion mixture fol-
lowed by gel puriﬁcation of the isolated fragment. We
recommend to purify the ampliﬁed pCRi vector frag-
ment (9800 bp) from a gel and to use it as template
for further applications.
ii. Dissolve the two spacer oligonucleotides in water at
a ﬁnal concentration of 100 lM. Phosphorylate and
anneal the oligonucleotides in a thermocycler. This
can be performed in a single 10 ll reaction contain-
ing 6 ll of water, 1 ll of each oligonucleotide solu-
tion, 1 ll of T4 ligase buffer and 1 ll of T4 PNK
(New England Biolabs Inc.). Use the following tem-
perature protocol: 30 min at 37°C, 4 min at 95°C, fol-
lowed by 70 cycles consisting of 12 s each, starting
at 95°C and decreasing the temperature by 1°C in
each cycle.
iii. Dilute the annealed and phosphorylated oligonu-
cleotides 1:200 with water, that is to a ﬁnal concen-
tration of double-stranded DNA (dsDNA) of 50 nM.
Ligate the dsDNA encoding the spacer for sgRNA
into the linearized pCRi vector in a 10 ll reaction
containing 1 ll of diluted insert from the previous
step, 10 ng of BsaI-digested and puriﬁed pCRi vector
or its derivative, 1 ll of T4 ligase buffer, 1 ll of T4
DNA ligase (New England Biolabs Inc.) and water, if
needed, to reach the ﬁnal volume. Other ligases,
such as the QuickLigaseTM DNA ligase (New Eng-
land Biolabs Inc.) can be used as needed.
iv. Ligate 30 min at room temperature, and transform a
100-ll aliquot of chemically competent E. coli DH5a
cells with the total ligation mixture. Plate the bacterial
suspension on LB agar plates supplemented with
streptomycin. Purify plasmid DNA from three individ-
ual E. coli transformants, and verify the sequence
integrity by sequencing with primer EK.SEVA_T0-F
(Table S2 in the Supporting Information).
In order to repress multiple targets, several sgRNAs
should be cloned into the vector, each of them placed
under its own promoter. Individual PEM7 ? sgRNA mod-
ules are synthesized as ultramers (Integrated DNA Tech-
nologies, Leuven, Belgium). Multiple sgRNA ultramers
(i.e. containing promoter, target spacer, sgRNA fusion
construct and unique overhangs) have to be ampliﬁed
with the corresponding set of primers (depending on the
sequence) and assembled together into the selected
pCRiMs vector (Fig. 3), for example with USER cloning
(Cavaleiro et al., 2015). The AMUSER tool (Genee
et al., 2015) can be used to design primers with suitable
overhangs for the assembly (available online at http://
www.cbs.dtu.dk/services/AMUSER/).
Step-by-step procedure (cloning of a construct to target
multiple genes).
i. Amplify vector pCRi using 1–5 ng of plasmid as tem-
plate and primers EK.pCRi-U-F and EK.pCRi-U-R
(Table S2 in the Supporting Information) using Phu-
sionTM U Hot Start DNA polymerase according to the
manufacturer’s recommendations (Thermo Fisher
Scientiﬁc, Waltham, MA, USA), 3 min elongation
time, and employing an annealing temperature of
60°C for 30 cycles.
ii. Amplify double-stranded sgRNAs using synthesized
ultramer as a template and respective primers
(EK.sgRNA-F and EK.sgRNA-R; Table S2 in the
Supporting Information) using PhusionTM U Hot Start
DNA polymerase (according to the manufac-
turer’s recommendations), 20 s elongation time, and
annealing temperature of 60°C for 30 cycles.
iii. Combine equimolar amounts of sgRNAs and 100-
150 ng of pCRi derivative with 1 ll of 1 U ll1
USER enzyme (New England BioLabs Inc.) in a ﬁnal
volume of 10 ll. Incubate 30 min at 37°C or 20 min
at room temperature. Transform 50 ll of chemically
competent E. coli DH5a cells with 10 ll of the
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resulting mixture. Plate the cells on LB medium agar
supplemented with streptomycin.
Quickly verify correct constructs via PCR of 6-10 colo-
nies with primers EK.SEVA_T0-F and EK.sgRNA-R
(Table S2 in the Supporting Information). The size of the
band for the negative control (i.e. an empty pCRi vector)
is 210 bp; each spacer insert will yield a 195-bp longer
amplicon. Purify DNA from the remaining volume of the
PCR tubes that had the correct insert size and send the
samples for DNA sequencing for ﬁnal veriﬁcation. Inocu-
late cultures of two individual E. coli clones (having the
correct band size and sequence) in LB medium with
streptomycin and incubate the cultures overnight at 37°C
with shaking for further isolation of the plasmids.
One-step Golden Gate-based cloning for the assembly
of single or multiple spacers into the crRNA cassette. To
facilitate one-step Golden Gate assembly of a 30-nt
spacer into vector pGCRi, two single-stranded (ss) DNA
oligonucleotides have to be designed as shown in
Fig. 4A. First, the sense (S) and anti-sense (AS) ssDNA
oligonucleotides have to be annealed by slowly cooling
the mixture to form a double-stranded (ds) DNA spacer
unit (see section below) and later assembled with the
pGCRi vector by replacing the eforRed chromoprotein
sequence (Fig. 4A). This strategy enables ligation
without the need of prior linearization of the vector and
accelerates the screening process of the colonies that
have acquired the correctly assembled plasmid.
Construction of the multiplex crRNA array relies on the
same design with minor modiﬁcations, where two or
more dsDNA spacer-repeat units and one or more ds
trimmed-repeat units (depending on the number of
spacers) are ligated into the pGCRi vector (Fig. 4B).
Each oligonucleotide is ﬂanked by BsaI recognition sites,
allowing for the complete reconstruction of each DR as
all parts will be ligated into the pGCRi vector via Golden
Gate assembly (Fig. 4B). The 4-bp ssDNA overhangs
vary between the different oligo units by altering the
length of the trimmed-DR unit as the number of the
spacers in the crRNA is further extended. In this way,
incompatible 4-bp overhangs are created, allowing for
the construction of the multiplex crRNAs with the desired
orientation and order. Following this strategy, standard
ﬂanks and trimmed-DR units (where needed) were
designed for the construction of single, double and triple
crRNAs (Table 2). The dsDNA units can be reused in
conjunction with others to form new crRNAs with the
same number of spacers. For instance, any spacer1-
repeat unit of a double crRNA array is compatible with
the trimmed-repeat unit as well as with any spacer2-
repeat unit.
Step-by-step procedure (cloning of the construct to
target single or multiple genes).
i. Select the target spacer sequence (50?30) and
design the required oligonucleotide using the corre-
sponding standard ﬂanks given in Table 2. Order the
designed spacer oligonucleotide and its reverse com-
plement sequence as ssDNA oligonucleotides from a
commercial DNA synthesis vendor (e.g. Integrated
DNA Technologies).
ii. Dissolve the two ssDNA oligonucleotides at a ﬁnal
concentration of 100 lM and anneal them by setting
a single reaction consisting of 1 ll of each oligonu-
cleotide, 2.5 ll NaCl and 45.5 ll water. The reaction
Fig. 3. Assembly of pCRiMs vectors. Double-stranded sgRNA ultramers with unique target spacers are combined with a PCR-ampliﬁed pMCRi
vector for USER cloning reactions, resulting in a suite of vectors tailored for downregulation of several targets (i.e. pCRiMs plasmids)
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is incubated at 95°C for 5 min in a thermoblock, fol-
lowed by a slowly cooling down step of 2 h by leav-
ing the reaction tube inside the thermoblock at room
temperature.
iii. Ligate the dsDNA oligonucleotide encoding the
spacer into the pGCRi vector via a Golden Gate
reaction composed by 2 ll of the 1:100-diluted
annealed oligonucleotides (in case of multiplexing,
add 1 ll of each dsDNA spacer-repeat and trimmed-
repeat oligonucleotides), 2 ll of 15 ng ll1 pGCRi
plasmid and 2 ll of an in-house Golden Gate assem-
bly master mix [10 ll of non-high ﬁdelity (HF) BsaI
restriction enzyme (New England Biolabs Inc.), 15 ll
of T4 DNA ligase buffer (New England Biolabs Inc.),
10 ll of T4 DNA ligase (New England Biolabs Inc.),
1 ll of 20 mg ml1 bovine serum albumin (BSA) and
13.5 ll of water]. Incubate the reaction in a thermo-
cycler at 37°C for 5 min; 15 cycles of 16°C for 4 min
and 37°C for 3 min; 37°C for 5 min and 85°C for
10 min. Transform the resulting mixture into chemi-
cally competent E. coli DH5a cells.
iv. Select three white transformants for plasmid puriﬁca-
tion and verify through DNA sequencing of plasmid
DNA.
Plasmid delivery in Pseudomonas by electroporation
i. Inoculate 10 ml of LB medium with the P. putida
strain to be transformed and grow the cells overnight
at 30°C with agitation (170-200 rpm).
ii. Wash the cells three times with 1 ml of 300 mM
sucrose (ﬁlter-sterilized) and resuspend them in
400 ll of 300 mM sucrose.
iii. Individually electroporate 100 ng of empty pCRi vector
and 100 ng of pCRi vector with the target-speciﬁc gRNA
into 100-ll cell suspension aliquots with a voltage of
2.5 kV, 25 lF capacitance, and 200 Ω resistance (e.g.
in a Gene Pulser XcellTM Electroporation System, Bio-
Rad Laboratories Inc., Hercules, CA, USA).
iv. Let the cells recover in LB medium for 2 h at 30°C
with agitation and plate them onto LB agar
Fig. 4. Schematic representation of dsDNA spacer units and multiplex assembly strategy A. The annealed synthesized oligonucleotides consist
of the 30-nt target spacer sequence ﬂanked with four and ﬁve nucleotides (indicated in grey) of the upstream and downstream direct repeats
(DRs), respectively, and two BsaI recognition sites (highlighted in blue). The crRNA cassette also contains two BsaI recognition sites between
the DRs with an intervening eforRed chromoprotein gene to facilitate the cloning of the intended double-stranded DNA (dsDNA) spacer unit. B.
Scheme of the dsDNA oligonucleotides required for the construction of a double crRNA array via Golden Gate cloning. The double-stranded
(ds) spacer1-repeat unit consists of the 30-nt spacer1 sequence (yellow) with additional four and six nucleotides of its upstream and downstream
DRs (grey) respectively. The ds spacer2-repeat unit consists of the 30-nt spacer2 sequence (green) with six and ﬁve nucleotides of its upstream
and downstream DRs (grey) respectively. The trimmed-DR unit consists of the DR sequence lacking the nucleotides that are present in the
spacer-repeat units. After digestion with BsaI, all dsDNA oligonucleotides display compatible overhangs that specify their order and directionality
as they are ligated to the target pGCRi vector via Golden Gate cloning
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supplemented with streptomycin (100 lg ml–1). Incu-
bate the plates overnight at 30°C.
Downregulation of the target gene(s) with CRISPRi
The plate with P. putida cells harbouring a pCRi plasmid
with a functional gRNA should have a repressed gene of
interest within 2 h after induction with 3-mBz (for the
maximal downregulation we recommend to use the indu-
cer at 1 mM). Inoculate the culture medium of interest
with P. putida harbouring the derivative of pCRi plasmid
with target-speciﬁc gRNA(s), and grow the cells over-
night at 30°C with agitation as indicated above. We rec-
ommend to supplement the culture medium with
streptomycin (100 lg ml–1) to select for the pCRi vector
derivative.
Application examples
CRISPRi-mediated repression efﬁciency with different
inducible expression systems and tuning of SpdCas9
expression
We ﬁrst examined the efﬁciency of the target gene
repression with CRISPRi using different expression sys-
tems: XylS/Pm on the pMCRi plasmid, ChnR/PchnB on
the pCCRi plasmid and CprK1/PDB3 on the pDCRi plas-
mid, which all drive SpdCas9 expression (Fig. 5A). To
determine the capability of the newly established CRIS-
PRi system for regulation of heterologous gene expres-
sion, we used P. putida strain KTBG42, harbouring a
msfgfp gene (encoding the monomeric super-folder
green ﬂuorescent protein, msfGFP) and a gentamicin
resistance marker in the unique Tn7 locus of the bacte-
rial chromosome (Zobel et al., 2015; Volke et al., 2020;
see Table S1 in the Supporting Information). Each pCRi
vector was transformed into strain KTBG42, and cells
were grown at 30°C on LB medium plates, containing
both 100 lg ml1 streptomycin (to select for the plas-
mid) and 20 lg ml1 gentamicin (to select for the Tn7
insertion). Three single colonies were then individually
inoculated to set overnight pre-cultures into 3 ml of M9
minimal medium (6 g l1 Na2HPO4, 3 g l
1 KH2PO4,
1.4 g l1 (NH4)2SO4, 0.5 g l
1 NaCl, 0.2 g l1 MgSO4,
2.5 ml l1 of a trace elements solution; Nikel and de Lor-
enzo, 2013, 2014) containing 100 lg ml1 streptomycin
and 20 lg ml1 gentamicin. Cultures were incubated for
15 h at 30°C with agitation. Then, 5 ll of the preculture
was inoculated into 195 ll of M9 minimal medium con-
taining 100 lg ml1 streptomycin, 20 lg ml1 gentam-
icin and 1 mM of the corresponding inducer depending
on the expression system (XylS/Pm, induced by 3-mBz;
ChnR/PchnB, induced by cyclohexanone; and CprK1/
PDB3, induced by 3-chloro-4-hydroxyphenylacetic acid).
All inducers were directly added to the liquid culture
medium from stock, concentrated solutions. The CRIS-
PRi-mediated decrease of msfGFP ﬂuorescence in
P. putida KTBG42 transformed with different plasmids
varied across conditions depending on the expression
system. After 12 h of induction, the msfGFP ﬂuores-
cence in P. putida KTBG42/pMCRi_gfp (where
SpdCas9 expression is placed under control of XylS/Pm)
decreased by up to 90% compared with control P. putida
KTBG42 cells carrying an empty vector. When the
ChnR/PchnB or CprK1/PDB3 expression systems were
used under the same culture and induction conditions,
the msfGFP ﬂuorescence decreased by 65% and 80%
respectively (Fig. 5B).
In view of the results above, we concluded that the
XylS/Pm system outperformed the other expression sys-
tems for msfGFP depletion – thus we adopted this sys-
tem for gene downregulation in further experiments. To
analyse its tunability upon induction, we followed the
msfGFP ﬂuorescence levels of P. putida KTBG42 cells
carrying the corresponding CRISPRi vector in the pres-
ence of different concentrations of 3-mBz, ranging from
0 to 1 mM. Expectedly, the level of repression of
msfgfp expression increased as a function of the indu-
cer concentration (hence resulting in a graded
decrease in the ﬂuorescence levels in the cells;
Table 2. Standard ﬂanks and trimmed-direct repeats units for one-
step Golden Gate spacer assembly
Oligonucleotide Sequence (50?30)a
Single array
Spacer sense aggtctcaaaac–spacer–gtttttgagacca
Double array
Spacer1
sense
aggtctcaaaac–spacer1–gttttaagagacca
Trimmed-
repeat sense
aggtctcgtttagagctatgctgttttgaatggtcccaaacgagacc
Spacer2
sense
aggtctcacaaaac–spacer2–gtttttgagacca
Triple array
Spacer1
sense
aggtctcaaaac–spacer1–gttttaagagacca
Trimmed-
repeat1 sense
aggtctcgtttagagctatgctgttttgaatggtcccaaacgagacca
Spacer2
sense
aggtctcacaaaac–spacer2–gttttagtgagacca
Trimmed-
repeat2 sense
aggtctcgttagagctatgctgttttgaatggtcccaacgagacca
Spacer3
sense
aggtctcaccaaaac–spacer3–gtttttgagacca
aThe nucleotide sequences indicated in blue and red represent the
standard 50- and 30-ﬂanks respectively. Both standard ﬂanks incor-
porate BsaI recognition sites as well as unique sticky ends for direc-
tional cloning of the corresponding spacers and direct repeats
(DRs) into the crRNA array module. Each sense, single-stranded
(ssDNA) oligonucleotide listed in the table has to be annealed with
the corresponding anti-sense ssDNA oligonucleotide carrying the
exact reverse complement sequence to form the required double-
stranded (dsDNA) oligonucleotides.
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Fig. 6A). In particular, by using various concentrations
of 3-mBz (i.e. 0, 0.01, 0.1, 0.5 and 1 mM) we man-
aged to decrease msfGFP ﬂuorescence intensities up
to 15%, 55%, 63%, 66% and 88%, respectively, after
15 h of incubation.
In order to demonstrate how the system can be used
to modify a physiological property of the cells, we also
performed CRISPRi-mediated inhibition of the expres-
sion of ftsZ (PP_1342). This gene encodes the FtsZ pro-
tein that plays a key role in septum formation during
bacterial cell division (Lutkenhaus and Addinall, 1997;
Stricker and Erickson, 2003). Efﬁcient repression of ftsZ
leads to a ﬁlamentous cell phenotype, as previously
described by Elhadi et al. (2016) and Tan et al. (2018).
In this case, we showed that, contrary to other reported
CRISPRi systems, the very low leakiness of
the CRISPRi modules constructed in this study does not
result in any visible repression effect in the absence of
the inducer. Moreover, we found that gene repression
strictly depends on the amount of the inducer (i.e. 3-
mBz) added to the culture medium (Fig. 6B). Thus, the
present approach is suitable for homogenous and tun-
able gene repression by adjusting the amounts of
SpdCas9 in the cell.
CRISPRi-mediated downregulation of multiple targets
(mCRISPRi) in P. putida
The CRISPRi systems described above afford ﬂexibility
and modularity features that can be adapted depending
on the intended application. We wanted to further extend
the range of targets that can be suppressed following the
same design principle (mCRISPRi, multiplex CRISPRi).
To this end, and in order to express more than one gRNA
from a single plasmid, we constructed and adopted two
approaches: (i) a CRISPRi system equipped with several
Fig. 5. Titratable downregulation of msfgfp expression with CRISPRi using inducible expression systems to drive SpdCas9 expression A.
Schematic representation of derivatives of plasmid pCRi_gfp (plasmids pCCRi, pDCRi and pMCRi). All plasmids were separately introduced into
P. putida KTBG42, and three different expression systems were adopted: XylS/Pm (induced by addition of 3-methylbenzoate), ChnR/PchnB (in-
duced by addition of cyclohexanone) and CprK1/PDB3 (induced by addition of 3-chloro-4-hydroxyphenylacetic acid). B. CRISPRi experiment on
ﬂuorescent proteins. P. putida KTBG42 was used as a control [indicated in the ﬁgure as () CRISPRi], and grown on M9 minimal medium sup-
plemented with 0.2% (w/v) glucose and 20 lg ml1 gentamicin. P. putida KTBG42 transformants, harbouring the different CRISPRi vectors
indicated, were re-grown on M9 minimal medium supplemented with 0.2% (w/v) glucose, 100 lg ml–1 streptomycin, 20 lg ml1 gentamicin and
1 mM of the corresponding inducer [indicated in the ﬁgure as (+) CRISPRi]. Bacterial growth and msfGFP ﬂuorescence
(kexcitation/kemission = 485 nm/516 nm) were continuously measured during 15 h in a Synergy HI plate reader (BioTek Instruments, Inc.,
Winooski, VT, USA) using microtiter 96-well plates incubated at 30°C. Fluorescence readings were normalized to the bacterial growth (esti-
mated as the optical density measured at 600 nm). Each data point represents the mean value of the percentage of normalized ﬂuores-
cence  standard deviation from at least three biological replicates
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sgRNAs under control of individual PEM7 promoters, or (ii)
a system harbouring the native crRNA cassette with multi-
ple spacers (Fig. 7A). The detailed structure of the con-
structs was described in the previous sections. To perform
mCRISPRi, we ﬁrst constructed P. putida
KTYFPmCherry, harbouring constitutively expressed yfp
and mCherry genes – encoding yellow ﬂuorescent protein
(YFP) and red ﬂuorescent protein (mCherry), respectively
– and a kanamycin resistance marker integrated into the
Tn7 locus of the chromosome (Table S1 in the Supporting
Information). The design and construction of P. putida
KTYFPmCherry was done essentially according to Wirth
et al. (2020). P. putida KTYFPmCherry is a derivative of
wild-type strain KT2440 carrying a P100 ? mCherry and
Ptet ? yfp cassette integrated in the Tn7 locus via a syn-
thetic mini-Tn7 transposon. As such, this strain displays
constitutive expression of the two ﬂuorescent protein
genes driven by the P100 and Ptet promoters. We ﬁrst
assessed repression of either yfp or mCherry expression.
P. putida KT2440YFPmCherry harbouring the empty
pGCRi vector was used as a control was grown on M9
minimal medium supplemented with 0.2% (w/v)
glucose and streptomycin (100 lg ml1). P. putida
KT2440YFPmCherry harbouring pGCRi_yfp or pMCRi_
mCherry was grown under the same conditions. The cul-
tures were supplemented with 1 mM 3-mBz to induce the
XylS/Pm expression system. In this case, downregulation
of single-gene targets (yfp, mCherry) resulted in repres-
sion up to 65-68 % (Fig. S1A in the Supporting Informa-
tion).
Furthermore, and in order to simultaneously downreg-
ulate the expression of yfp, mCherry and ftsZ (which, as
indicated above, affects cell division and thereby results
in a ﬁlamentous phenotype), P. putida KTYFPmCherry
cells were ﬁrst transformed with constructs harbouring
multiple target-speciﬁc spacers (i.e. plasmids pCRiMs
and pCRiMc, Fig. 7A). Both systems exhibited similar
efﬁciency in repressing the chosen targets (an expected
result, considering that the spacer sequences in plas-
mids pCRiMs_yfp/mCherry/ftsZ and pCRiMc_yfp/
mCherry/ftsZ were the same; Table S2 in the Supporting
Information). Speciﬁcally, after 15 h of cultivation, the rel-
ative ﬂuorescence was reduced by 55%–65% for
mCherry and by 55%–60% for YFP (Fig. 7B). Note that,
Fig. 6. Tunable effect of the CRISPRi system in P. putida KTBG42 cells harbouring plasmid pMCRi with different inducer concentrations. A.
Strain KTBG42 cells transformed with plasmid pMCRi_gfp, harbouring the msfgfp-speciﬁc spacer [indicated in the ﬁgure as (+) CRISPRi] or
with vector pMCRi_non-target [harbouring a non-target-speciﬁc unique spacer, and indicated in the ﬁgure as (–) CRISPRi], were grown on M9
minimal medium with 0.2% (w/v) glucose, 100 lg ml–1 streptomycin, 20 lg ml1 gentamicin and different concentrations of 3-methylbenzoate
(3-mBz) in the 0 to 1 mM range. Bacterial growth and msfGFP ﬂuorescence (kexcitation/kemission = 485 nm/516 nm) were continuously measured
during 15 h in a Synergy HI plate reader (BioTek Instruments, Inc., Winooski, VT, USA) using microtiter 96-well plates incubated at 30°C. Fluo-
rescence readings were normalized to the bacterial growth (estimated as the optical density measured at 600 nm). Each data point represents
the mean value of the percentage of normalized ﬂuorescence  standard deviation from at least three biological replicates. B. Microscope pic-
tures showing tunable, inducer-dependent morphology changes of cells during CRISPRi-mediated downregulation of ftsZ in wild-type strain
KT2440. Pictures were taken after 15 h with a Leica 2000 LED microscopy system (Leica Microsystems GmbH, Germany) at 100 9 resolution
(F1 type emission oil)
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according to the measurement of ﬂuorescence levels,
the repression of the target gene in the absence of the
speciﬁc spacer was fairly comparable for the two CRIS-
PRi systems. Targeting of ftsZ with mCRISPRi resulted
in cell morphology changes (detectable under light
microscopy), with a signiﬁcant shift in the cell size from
ca. 5 lm rods to ﬁlament-like shaped cells with a length
up to 60 lm (Fig. 7C). Importantly, repression levels
remained within the same range (i.e. around 60%) during
multiple or single-gene targeting with CRISPRi (pCRiM-
c_yfp/mCherry/ftsZ or pGCRi_yfp, respectively; see
Fig. S1B in the Supporting Information). Thus, the sin-
gle-plasmid mCRISPRi system developed here allows
for regulatable downregulation of several genes of inter-
est, which was demonstrated by simultaneous repres-
sion of three genes in P. putida.
Fig. 7. CRISPRi-mediated downregulation of multiple gene targets (mCRISPRi) in P. putida KTYFPmCherry. For simultaneous repression of
the expression of mCherry, yfp and ftsZ, cells containing the corresponding CRISPRi vector were grown in M9 minimal medium with 0.2% (w/v)
glucose, supplemented with 100 lg ml–1 streptomycin, 50 lg ml–1 kanamycin and induced with 3-methylbenzoate at 1 mM. In the ﬁgure, (–)
mCRISPRi represents cells harbouring a non-target-speciﬁc pMCRi vector, and (+) mCRISPRi represents cells containing pCRiMs vector. A.
Schematic representation of vectors pCRiMs and pCRiMc, harbouring target-speciﬁc spacers. (B) Bacterial growth and mCherry ﬂuorescence
(kexcitation/kemission = 567 nm/610 nm) and YFP ﬂuorescence (kexcitation/kemission = 495 nm/527 nm) were measured at 15 h in a Synergy HI plate
reader (BioTek Instruments, Inc., Winooski, VT, USA) using microtiter 96-well plates incubated at 30°C. Fluorescence readings were normalized
to the bacterial growth (estimated as the optical density measured at 600 nm). Basal levels of ﬂuorescence detected in P. putida KT2440 were
also subtracted from the reading. Each bar represents the mean value of the percentage of normalized ﬂuorescence  standard deviation from
at least three biological replicates. B. Microscope pictures showing morphology changes of cells during mCRISPRi-mediated downregulation of
ftsZ in wild-type strain KT2440 after 15 h. Pictures were taken with a Leica 2000 LED microscopy system (Leica Microsystems GmbH,
Germany) at 100 9 resolution (F1 type emission oil)
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Characterization of the RecA-dependent genetic stability
of the system using CRISPRi-mediated downregulation
of pyrF
Several teams have employed CRISPRi-based technolo-
gies to arrest cell growth by targeting essential chromo-
somal loci. In particular, CRISPRi has been successfully
deployed in engineered bacteria to redirect carbon ﬂuxes
from cell growth to production (Li et al., 2016; Shabes-
tary et al., 2018; Kent and Dixon, 2019; Tian et al.,
2019), thereby enhancing yields and titres of target com-
pounds. CRISPRi approaches have also been imple-
mented for high-throughput functional characterization of
putative essential genes in bacterial platforms such as
Bacillus subtilis (Peters et al., 2016), Streptococcus
pneumoniae (Liu et al., 2017) and Vibrio natriegens (Lee
et al., 2019). However, it has been shown that long-term
repression of essential loci often results in accumulation
of deleterious mutations in dCas9 and/or the gRNAs (or
regulatory elements thereof), eventually resulting in their
inactivation (Zhao et al., 2016).
In order to characterize the stability and long-term
efﬁciency of gene repression mediated by our CRISPRi
system in P. putida, we downregulated the expression
of pyrF (PP_1815), encoding the key orotidine 50-phos-
phate decarboxylase reaction within the pyrimidine
biosynthetic pathway. Following the protocol described
above, we implemented the pyrF-speciﬁc CRISPRi vec-
tors pGCRi_pyrF and pMCRi_pyrF (Table 1). As
expected, downregulation of pyrF led to signiﬁcantly
low growth rates when the cells were grown in M9 min-
imal medium with glucose as the only carbon source
(Table 3). In particular, and during the ﬁrst 10 h of culti-
vation, the growth of P. putida KT2440 cells harbouring
target-speciﬁc pCRi_pyrF vectors was repressed up to
90% (Fig. 8A,B). After 10 h, however, bacterial growth
resumed, a phenomenon which could be accounted for
by the accumulation of mutations in key elements of
the CRISPRi system – probably including homologous
recombination between the two DRs of the crRNA mod-
ule and further overgrowth of escapers cells in which
the expression of pyrF is no longer repressed.
We further analysed the sequence of the constructs
in the pyrF-downregulated strains harvested at the end
of the growth-inhibition experiments, and the results
indicated that multiple modiﬁcations were accumulated
in the constructs, including (i) recombination events
between the two DRs of the crRNA cassette that led
to the loss of the target spacer (which could be even
noticed by PCR ampliﬁcation of the cassette and sep-
arating the amplicons by gel electrophoresis, see
Fig. S2 in the Supporting Information) and (ii) point
mutations in the promoter sequence and/or the coding
sequence of GCSpCas9 itself (data not shown). To
suppress these deleterious effects, and to further char-
acterize the genetic stability of the target-speciﬁc
CRISPRi system, we repeated the growth-inhibition
experiment using P. putida strain EM383, a stream-
lined, reduced-genome strain derivative of KT2440
lacking several non-adjacent genomic deletions, includ-
ing the whole ﬂagellar machinery, four prophages, two
transposons and three key components of DNA restric-
tion-modiﬁcation systems (Martınez-Garcıa et al.,
2014). This reduced-genome strain also lacks the gene
encoding the main component of the homologous
recombination machinery, recA, preventing any further
recombination (Abella et al., 2007; Akkaya et al.,
2019). We reasoned that such strain would give rise
to a limited fraction of escapers upon CRISPRi-medi-
ated downregulation of essential genes. Indeed, the
growth arrest in strain EM383, mediated by targeting
the essential pyrF gene with CRISPRi, was extended
from 10 to 20 h (Fig. 8; Table 3). Moreover, wild-type
strain KT2440, expressing either the crRNA or sgRNA
module targeting pyrF, reached a 59% and 56% lower
optical density after 20 h compared with the control
experiments respectively. At the same time, strain
EM383 harbouring the same CRISPRi plasmids
showed almost no growth after 20 h in contrast to the
corresponding controls. These results indicate a clear
role for RecA on the genetic stability of CRISPRi
Table 3. Growth characterization of wild-type P. putida KT2440 and
the streamlined strain EM383 upon CRISPRi-mediated downregula-
tion of pyrF expression
P. putida strain
Growth parameter
Speciﬁc growth ratea
(h1)
Final optical den-
sityb
KT2440 0.27  0.08 1.78  0.09
EM383 0.33  0.05 1.78  0.08
KT2440/pGCRi_no
target
0.19  0.02 2.59  0.03
EM383/pGCRi_no
target
0.12  0.01 2.32  0.18
KT2440/pGCRi_pyrF N.D. 1.05  0.27
EM383/pGCRi_pyrF N.D. 0.42  0.05
KT2440/pMCRi_no
target
0.24  0.02 1.75  0.09
EM383/pMCRi_no
target
0.28  0.07 1.73  0.09
KT2440/pMCRi_pyrF N.D. 0.71  0.07
EM383/pMCRi_pyrF N.D. 0.15  0.09
aThe speciﬁc growth rate for each strain was calculated during
exponential growth. Cultures were carried out in 96-well microtiter
plates, and the optical density at 600 nm was measured every
15 min during 20 h using a Synergy HI Biotek microplate reader
(BioTek Instruments, Inc., Winooski, VT, USA). Glucose was added
as a carbon source to M9 minimal medium at 0.2% (w/v). ’Results
represent the mean and standard deviation of two independent
experiments. N.D., not detected.
bThe ﬁnal optical density at 600 nm is reported for each strain after
20 h of incubation.
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systems in P. putida, which can be circumvented by
using strains in which the recombination machinery
has been eliminated.
Discussion
CRISPRi technologies have been widely applied for
metabolic engineering and synthetic biology approaches
in a range of eukaryotic and prokaryotic organisms.
CRISPRi systems have been successfully optimized for
a range of bacterial chassis including E. coli, Bacillus
subtilis and Corynebacterium glutamicum (Jakociunas
et al., 2017; Adli, 2018; Cho et al., 2018; Donohoue
et al., 2018). In the present work, we aimed at improving
the existing CRISPRi-based genome engineering toolbox
for P. putida, implementing modularity, robustness and
tunability towards the development of this bacterium as
an effective, efﬁcient and controllable chassis for
biotechnological applications. These features are sepa-
rately discussed in the sections below.
Tunable gene regulation and multiplexing
Two variants of a single-plasmid CRISPRi system (either
sgRNA-based or crRNA-based) were developed for the
transcriptional control of gene expression in P. putida.
Tight and tunable downregulation of gene expression
was achieved through controlling the expression of
SpdCas9 with the XylS/Pm system. Furthermore, the
system displayed low leakiness – up to 15% (when
downregulating the expression of msfgfp, mCherry or
yfp) or non-detectable (in the case of targeting ftsZ)
under non-induced conditions. A linear response of
downregulation levels of a chromosomally expressed
msfgfp was observed as a function of the inducer (3-
mBz) concentration. This feature represents a substan-
tial improvement to previously CRISPRi-based
approaches, which did not allow for titratable gene
downregulation (Kim et al., 2020), sometimes exhibiting
high leakiness (> 50%) in the absence of the corre-
sponding inducers (Tan et al., 2018). Importantly, we
also demonstrated the ability to simultaneously downreg-
ulate three genes in P. putida with this system.
Inducible downregulation through CRISPRi enables
conditional control of essential gene expression. Such
an approach would be effective for controlling growth
(e.g. to establish growth-decoupling switches for biopro-
duction; Durante-Rodrıguez et al., 2018) or for the
assessment of fundamental questions in metabolism
(e.g. related to gene essentiality; Poulsen et al., 2019).
As an example, we applied the versatile CRISPRi sys-
tem described in this study to control the expression of
the conditionally essential gene pyrF. The growth of P.
putida strains harbouring either the sgRNA- or crRNA-
based CRISPRi vectors was totally suppressed during
the ﬁrst 10 h in a minimal culture medium supplemented
with glucose as sole carbon source. Additionally, we
demonstrated a signiﬁcant increase in the stability of the
CRISPRi repression when essential genes are targeted
in a strain devoid of the RecA machinery, which points
to the importance of RecA-dependent mechanisms for
stability of genetic constructs in P. putida (Aparicio et al.,
2020). Therefore, the expanded, single-plasmid CRISPRi
toolbox combines all the essential features desired for
precise transcriptional control of single and multiple
genes in P. putida.
Cloning, standardization and modularity of CRISPRi
components and portability
In addition to the examples illustrating the applicability of
the tool, we also focused on improving cloning
Fig. 8. CRISPRi-based, targeted downregulation of pyrF expression
in P. putida. Wild-type KT2440 and the streamlined P. putida strain
EM383 were transformed with either non-target-speciﬁc vectors
pGCRi or pMCRi, or the corresponding target-speciﬁc vectors (indi-
cated with the sufﬁx pyrF). The resulting strains were grown in 96-
well plates in M9 minimal medium supplemented with 0.2% (w/v)
glucose, 100 lg ml–1 streptomycin and 1 mM 3-methylbenzoate.
Bacterial growth was monitored in a Synergy HI plate reader (Bio-
Tek Instruments, Inc., Winooski, VT, USA) for 20 h at 30°C with
shaking by periodically measuring the optical density at 600 nm
(OD600). Gene repression experiments are indicated for cells trans-
formed with (A) plasmid pGCRi (no target and pyrF-speciﬁc) and (B)
plasmid pMCRi (no target and pyrF-speciﬁc). Each data point repre-
sents the mean value of OD600 readings  standard deviation of at
least three biological replicates
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procedures and implementing standardization and modu-
larity in the intervening components of the CRISPRi sys-
tem. Two detailed protocols are provided for the
construction of multiplex sgRNA and crRNA arrays. In
general, the efﬁciency of using just sgRNA or both
tracrRNA and crRNA was observed to be fairly compara-
ble. The architecture of crRNA allows for a rapid and sim-
ple cloning strategy when generating multiplex crRNA
arrays. In particular, the construction of multiplex gRNA
arrays has been shown to be a laborious and time-con-
suming process, where often additional PCR or ligation
steps are required. The genetic architecture of the sgRNA
(promoter–SpCas9 handle–terminator) limits the applica-
bility of several assembly methods that rely on the ligation
of homologous sequences – but it is particularly useful
and straightforward when targeting a single or dual target
(s) for downregulation. To tackle this problem, we con-
structed the crRNA-based CRISPRi vector (pGCRi),
which enables the construction of the array with multiple
spacers in a modular and directional single step with all
elements in the array regulated by a master promoter. In
addition, the pGCRi vector is equipped with the gene
encoding an eforRed chromoprotein that gets inactivated
if the spacers are correctly integrated into the vector, sim-
plifying and accelerating the selection process. Therefore,
vector pGCRi (and derivatives) is suitable for combinato-
rial, high-throughput genetic screenings where hundreds
or thousands of CRISPRi plasmids need to be built (Reis
et al., 2019). In terms of overall impact of the different
CRISPRi systems presented herein on the cell physiol-
ogy, we would recommend to use plasmids containing
SpdCas9 due to limited effects on bacterial growth
parameters as compared with GCSpdCas9-bearing vec-
tors.
In conclusion, the present study describes suitable
strategies based on CRISPRi to efﬁciently control tran-
scription levels in P. putida KT2440 while implementing
modularity, standardization and robustness. Along the
line, low leakiness levels and tunable repression of sin-
gle and multiple genes has been achieved, and detailed
protocols for the construction of both sgRNA- and
crRNA-based CRISPRi vectors are provided (which can
be adapted at the user’s will, depending on the intended
application and its speciﬁc needs). Considering that all
the components of the CRISPRi toolbox presented in
this study follow the modular and standard formatting
brought about by the SEVA platform, the vectors pre-
sented in this work can be transferred to other Pseu-
domonas species – and, essentially, to any other Gram-
negative bacterium where an appropriate combination of
antibiotic resistance markers and origin of replications
from the SEVA collection can be used. Preliminary tests
in P. aeruginosa PAO1 indicate that SpdCas9-based
CRISPRi on genes encoding ﬂuorescent proteins yield
similar levels of repression as those reported herein
(data not shown), which sheds a positive light on the
system portability across species. As such, our study
considerable expands the CRISPRi toolbox of Pseu-
domonads and opens new avenues for functional char-
acterization of genes and advanced metabolic
engineering.
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